News

Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up

LH launches the first FDA-cleared blood test for Alzheimer's, boosting access to early diagnosis and nudging its stock higher.

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid 42 Ratio, the first blood-based ...
Pharmabiz4d

Labcorp introduces US FDA approved blood test, Lumipulse pTau-217/Beta Amyloid 42 Ratio for Alzheimer's disease

Labcorp introduces US FDA approved blood test, Lumipulse pTau-217/Beta Amyloid 42 Ratio for Alzheimer's disease: Burlington, North Carolina Tuesday, August 19, 2025, 14:00 Hrs [IS ...

Labcorp Launches FDA-Cleared Blood Test for Alzheimer's Disease

Labcorp has launched the first blood-based in-vitro diagnostic test cleared by the Food and Drug Administration to aid in the diagnosis of Alzheimer's disease.
McKnight's Long-Term Care News2d

FDA clears first blood test to aid in Alzheimer’s diagnosis

Seniors experiencing memory problems and cognitive decline now have access to a new diagnostic blood test to detect Alzheimer’s disease. Labcorp this week unveiled the first Food and Drug ...
MedPage Today on MSN4d

Brain Parts That Defy Aging; Decoding Inner Speech; Alzheimer's Test Hits the Market

Prenatal exposure to chlorpyrifos -- mostly attributable to indoor residential spraying for pests, prevalent in inner-city ...
PharmiWeb5d

Alzheimer’s Disease Diagnostic Market Poised for Robust Growth amid Innovations in Early Detection

FutureWise Research today announces the upcoming release of its comprehensive report, Alzheimer’s Disease Diagnostic Market – ...